Engelberg Center for Health Care Reform, Brookings Institution, Washington DC, USA.
Nat Rev Drug Discov. 2011 Feb;10(2):79-80. doi: 10.1038/nrd3360.
A well-defined pathway for the accelerated development and approval of targeted cancer therapies and companion diagnostics would reduce uncertainty, improve efficiency in development and provide an effective incentive for developers.
一个明确的途径，用于加速靶向癌症疗法和伴随诊断的开发和批准，将减少不确定性，提高开发效率，并为开发者提供有效的激励。
